The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Kiron and Kamala Das Symposium — Precision Medicine in IBD: The Road Ahead
Date
May 18, 2024
SOCIETY: AGA With the expansion of IBD treatment options, there is increasingly the need for predictive models to determine which treatments work best for which patients with IBD.
Presentations:
PROGNOSTICATION OF DISEASE COURSE IN IBD: THE PRESENT AND THE FUTURE
CAN CLINICAL PHENOTYPES AID IN PICKING THE RIGHT THERAPY FOR YOUR PATIENT?
STATISTICAL METHODS FOR THERAPEUTIC SEQUENCING: META-ANALYSES AND NETWORK META-ANALYSES
THE EMERGING ROLE OF MULTI-OMICS IN PERSONALIZING IBD THERAPY
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…